Celgene (CELG) volatility elevated into acquiring Juno Therapeutics for approximately $87 per share in cash

Celgene (NASDAQ: CELG) January weekly call option implied volatility is at 46, February is at 33; compared to its 52-week range of 17 to 38 into acquiring Juno Therapeutics (JUNO) for approximately $87 per share in cash.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Ishares Msci South Korea Capped Etf (EWY) spreader of 10K contracts January 170 and 190 puts into Korean market lower
• SpaceX (SPCX) call put ratio 1.1 calls to 1 put